Dr. Deepak Bhatt Discusses Results From the ENTRIGUE Trial

SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack

Raymond Benza, MD, Heart Failure Expert, Named Chief of Pulmonary Hypertension for the Mount Sinai Health System

Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research

Mount Sinai Announces Partnership With the Brazilian Clinical Research Institute to Advance Cardiovascular Disease Research and Medical Education

Do You Need to Monitor Your Blood Pressure at Home?

Experts' Perspective: Top Cardiology News from ACC 23

Sean Pinney, MD, Heart Failure Expert, Named Chief of Cardiology at Mount Sinai Morningside

Does EPA Lower CV Risk? REDUCE-IT Revisited

Difference between cardiac arrest and heart attack after Damar Hamlin's collapse

Dr. Deepak Bhatt named director of Mount Sinai Heart